PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1193
https://www.valueinhealthjournal.com/article/S1098-3015(12)01258-2/fulltext
Title :
PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01258-2&doi=10.1016/j.jval.2012.03.1193
First page :
A221
Section Title :
Cancer
Open access? :
No
Section Order :
720